Haugland Sjøtransport AS has been acquired by Scanbio Marine Group AS
The Norwegian Scanbio Marine Group AS (Scanbio), owned by the private equity firm Paine & Partners LLC, has acquired Haugland Sjøtransport AS. Financial details have not been disclosed.
Haugland Sjøtransport AS is an independently owned and operated Norwegian company, headquartered in Kleppestø, which owns two state-of-the-art vessels, the Haugfjord and Haugbas, which are leased to Tank og Masse-Transport AS. The vessels are specially modified for use in and around aquaculture facilities.
Scanbio was established in 1984 in Bjugn, Norway. The company specializes in the production of fish protein concentrate, fish oil and fishmeal from preserved by-products (silage) and fresh raw materials. Scanbio has three production plants in Norway and sales operations in Scotland.
New York-based Paine & Partners provides equity capital for management buyouts, going private transactions, and company expansion and growth programs. The firm currently makes investments through its US$1.2 billion fund, Paine & Partners Capital Fund III, L.P. and related entities.
Oaklins' team in Norway acted as financial advisor to the seller in this transaction.
Talk to the deal team
Related deals
Top Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider
Holland Capital, a Netherlands-based private equity firm, has acquired a stake in Top Systems, a leading provider of complete battery-based power solutions, with a unique value-added services proposition.
Learn moreInfotreasury has been sold to Matera
Matera, a leading banking software company with world-class instant payments and core banking solutions, has acquired Infotreasury.
Learn moreThrive Freeze Dry has successfully sealed the acquisition deal with Paradiesfrucht GmbH
Paradiesfrucht GmbH, a gobal freeze dryer of fruits, fruit preparations, drops, powders and granulates, has been acquired by Thrive Freeze Dry (Thrive), a portfolio company of Entrepreneurial Equity Partners (e2p) and Mubadala Capital. The transaction is expected to close in 2024, subject to customary closing conditions, including antitrust approval.
Learn more